"Situé dans la ville d'Antony (agglomération parisienne), l'Hôpital privé d'Antony, établissement du groupe Ramsay Santé, est né de la fusion de plusieurs établissements de santé. En résultent de vastes capacités d'accueil : en 2014, près de 30 000 patients ont été accueillis en chirurgie dont 22 000 en ambulatoire et 21 000 en médecine. En parallèle, plus de 3300 bébés sont nés à la Maternité de l’Hôpital d’Antony. Fortes de leur expérience, les équipes de l’établissement vous accueillent dans les meilleures conditions possibles lors de votre séjour."

During the past decade, Hôpital Privé d'Antony conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 4 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 4 clinical trials were completed. i.e. 19% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Privé d'Antony" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 8 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 6 trials sponsored, "Ramsay Générale de Santé" with 4 trials sponsored, "French Society for Intensive Care" with 3 trials sponsored and "Nantes University Hospital" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Privé d'Antony" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Privé d'Antony" are "Coronary Artery Disease" (3 trials), "Surgery" (3 trials), "Intensive Care Unit Syndrome" (2 trials), "Metastatic Colorectal Cancer" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Hôpital Privé d'Antony" in a lesser frequency.

Most popular intervention types in "Hôpital Privé d'Antony" are "Drug" (21 trials), "Other" (9 trials), "Device" (7 trials), "Procedure" (5 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Bevacizumab" (4 trials), "Gemcitabine" (3 trials), "Docetaxel" (2 trials) and "FOLFIRI Protocol" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Privé d'Antony" are 46 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hôpital Privé d'Antony". 1 are not yet recruiting, 14 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Hôpital Privé d'Antony, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Privé d'Antony, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".